Search research articles
Contact Us
Filters
Showing results (91-100 of 165) with videos related to
Page
of 17
Sort By:
Chemmedchem
|
June 14, 2026
Development of a Brain-Penetrant Nurr1 Agonist Tool
Jan Vietor, Tanja Stiller, Christian Gege, et al.
Science Advances
|
June 12, 2021
Combining generative artificial intelligence and on-chip synthesis for de novo drug design
Francesca Grisoni, Berend J H Huisman, Alexander L Button, et al.
Journal of Medicinal Chemistry
|
December 19, 2022
Rational Design of a New RXR Agonist Scaffold Enabling Single-Subtype Preference for RXRα, RXRβ, and RXRγ
Gustave Adouvi, Laura Isigkeit, Úrsula López-García, et al.
Chemmedchem
|
March 10, 2023
Development of Light-Activated LXR Agonists
Tufan K Mukhopadhyay, Sabine Willems, Christopher J Arp, et al.
Chemmedchem
|
April 15, 2021
Development and in vitro Profiling of Dual FXR/LTA4H Modulators
Simone Schierle, Steffen Brunst, Moritz Helmstädter, et al.
Chemical Science
|
March 20, 2020
Optical control of the nuclear bile acid receptor FXR with a photohormone
Johannes Morstein, Julie B Trads, Konstantin Hinnah, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 30, 2022
Nurr1 Modulation Mediates Neuroprotective Effects of Statins
Sabine Willems, Julian A Marschner, Whitney Kilu, et al.
ACS Medicinal Chemistry Letters
|
September 19, 2019
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences
Julius Pollinger, Simone Schierle, Leonie Gellrich, et al.
Bioconjugate Chemistry
|
May 25, 2026
Enhanced Intramuscular mRNA Activity of Peptide-Lipid Nanoparticles with Hydrophobized Head Groups
Eric Weidinger, Tobias Burghardt, Lennart Obeser, et al.
Journal of Medicinal Chemistry
|
February 7, 2025
A Nurr1 Agonist Derived from the Natural Ligand DHI Induces Neuroprotective Gene Expression
Markus Egner, Romy Busch, Úrsula López-García, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 165) with videos related to
Sort By:
Page
of 17
Chemmedchem
|
June 14, 2026
Development of a Brain-Penetrant Nurr1 Agonist Tool
Jan Vietor, Tanja Stiller, Christian Gege, et al.
Science Advances
|
June 12, 2021
Combining generative artificial intelligence and on-chip synthesis for de novo drug design
Francesca Grisoni, Berend J H Huisman, Alexander L Button, et al.
Journal of Medicinal Chemistry
|
December 19, 2022
Rational Design of a New RXR Agonist Scaffold Enabling Single-Subtype Preference for RXRα, RXRβ, and RXRγ
Gustave Adouvi, Laura Isigkeit, Úrsula López-García, et al.
Chemmedchem
|
March 10, 2023
Development of Light-Activated LXR Agonists
Tufan K Mukhopadhyay, Sabine Willems, Christopher J Arp, et al.
Chemmedchem
|
April 15, 2021
Development and in vitro Profiling of Dual FXR/LTA4H Modulators
Simone Schierle, Steffen Brunst, Moritz Helmstädter, et al.
Chemical Science
|
March 20, 2020
Optical control of the nuclear bile acid receptor FXR with a photohormone
Johannes Morstein, Julie B Trads, Konstantin Hinnah, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 30, 2022
Nurr1 Modulation Mediates Neuroprotective Effects of Statins
Sabine Willems, Julian A Marschner, Whitney Kilu, et al.
ACS Medicinal Chemistry Letters
|
September 19, 2019
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences
Julius Pollinger, Simone Schierle, Leonie Gellrich, et al.
Bioconjugate Chemistry
|
May 25, 2026
Enhanced Intramuscular mRNA Activity of Peptide-Lipid Nanoparticles with Hydrophobized Head Groups
Eric Weidinger, Tobias Burghardt, Lennart Obeser, et al.
Journal of Medicinal Chemistry
|
February 7, 2025
A Nurr1 Agonist Derived from the Natural Ligand DHI Induces Neuroprotective Gene Expression
Markus Egner, Romy Busch, Úrsula López-García, et al.
Page
of 17